The Sweet Pee model for Sglt2 mutation - Wikidata - wikimedia - TriplyDB

The Sweet Pee model for Sglt2 mutation

The Sweet Pee model for Sglt2 mutation

http://www.wikidata.org/entity/Q34457273

about

Sodium-glucose cotransporter 2 inhibition: cardioprotection by treating diabetes-a translational viewpoint explaining its potential salutary effects Proximal nephron Investigational anti-hyperglycemic agents: the future of type 2 diabetes therapy?Structural selectivity of human SGLT inhibitors.Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus Glucose metabolism in the Belgrade rat, a model of iron-loading anemia Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney.Nephron filtration rate and proximal tubular fluid reabsorption in the Akita mouse model of type I diabetes mellitus.SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice.Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia.SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects.Dapagliflozin: a novel sodium-glucose cotransporter type 2 inhibitor for the treatment of type 2 diabetes mellitus.Coming full circle in diabetes mellitus: from complications to initiation.Differentiating sodium-glucose co-transporter-2 inhibitors in development for the treatment of type 2 diabetes mellitus.Probing SGLT2 as a therapeutic target for diabetes: basic physiology and consequences.A comprehensive review of the pharmacodynamics of the SGLT2 inhibitor empagliflozin in animals and humans.SGLT2 Inhibitors: Glucotoxicity and Tumorigenesis Downstream the Renal Proximal Tubule?The next generation of therapeutics for chronic kidney disease Effect of diuretics on renal tubular transport of calcium and magnesium.SGLT2 deletion improves glucose homeostasis and preserves pancreatic beta-cell function Modelling diabetic nephropathy in mice.Urine: Waste product or biologically active tissue?Interaction Between the Sodium-Glucose-Linked Transporter 2 Inhibitor Dapagliflozin and the Loop Diuretic Bumetanide in Normal Human Subjects.Protective Effects of Glucagon-Like Peptide-1 Analog on Renal Tubular Injury in Mice on High-Fat Diet.Improved glycemic control in mice lacking Sglt1 and Sglt2.

P2860

Q28072765-58A2F1EA-ABFB-4F89-AE1E-D2AF0DBA5358 Q28388052-13A84514-D16F-4F7C-94DF-45E72A69BECB Q30426407-14E31DB0-CF6A-4555-87CF-BFCCA8401F13 Q35895528-3A4D5897-39CA-4BAC-A41F-9B522674F049 Q36527897-E5AAEBAD-68D7-4615-B5D5-45DAE103C6EB Q36923755-947D1A87-707C-4275-9EA4-9AB0DCB36828 Q37253944-0ED59BC8-3025-48F7-9297-D970D0C42CD5 Q37272531-FB526BEE-244D-4289-B0E8-E71B23897059 Q37575455-8B12EFB3-86C1-451C-B818-F7A51F9DC82C Q37575461-E3A8AC84-1646-4F0A-8802-0708BE679168 Q37981884-4A5C2650-1452-4BDA-AD52-94FB30BD111F Q37990891-F658F040-6D03-4185-98DD-425BEF3BA080 Q38072272-6AE2DACB-B391-469D-8587-DD999DFF08D3 Q38085691-D11C820F-FA4D-400C-8F1E-162638A8B815 Q38330456-361FC65D-BBF1-4C9A-89F4-6F416CD21E3A Q38537119-61D5AC6F-F999-4C8A-BD63-F4F1C62FCC54 Q38667712-280844EB-07A1-4482-9965-B6DC64AD7AA2 Q38845590-FC523271-24A2-486E-81FE-6F4B9E455306 Q39169297-F5E26BC0-1161-48C9-A3FD-6638CE901F63 Q42153763-ED6A9179-5F6A-49E7-8FB1-CF9BDE6562D0 Q47735079-27C80702-9A35-4CE7-8396-45D55B2C5534 Q49719924-E77F7F70-3397-4FC0-B47A-B1D84A7856A4 Q50027868-C2AE6D5D-C4B5-4037-9C98-2410005E85AF Q51118569-E079EEE7-0315-4269-B059-6493B5267B12 Q51349034-6E99BE97-7E1A-41E6-8A4D-69AD04365AA8

P2860

The Sweet Pee model for Sglt2 mutation

http://www.wikidata.org/entity/Q34457273

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

The Sweet Pee model for Sglt2 mutation

@ast

The Sweet Pee model for Sglt2 mutation

@en

The Sweet Pee model for Sglt2 mutation

@nl

type

label

The Sweet Pee model for Sglt2 mutation

@ast

The Sweet Pee model for Sglt2 mutation

@en

The Sweet Pee model for Sglt2 mutation

@nl

prefLabel

The Sweet Pee model for Sglt2 mutation

@ast

The Sweet Pee model for Sglt2 mutation

@en

The Sweet Pee model for Sglt2 mutation

@nl

P1433

Q34457273-7ADEC01C-2CDF-4989-8C91-83C00B2A4A88

P1476

Q34457273-25395041-753A-4413-8C73-09DABB9AAAE7

P2093

Q34457273-029CB7E8-6BB7-4367-AD1B-E0962D691B17

Q34457273-0A290312-AB2D-4BA1-98FC-AA1DFA23F867

Q34457273-3389D0CB-EFBE-48CF-BB75-9007C213E501

Q34457273-457FD832-D1B0-4504-AA8D-FD127DC56BE8

Q34457273-649B82FE-7CE3-4867-8755-4EE20B8DC7D4

Q34457273-6DEFEADF-F31D-4FF2-8260-1F9EB0C1B776

Q34457273-C159BBCB-4F08-4B24-9093-CB4A4D5414A1

Q34457273-C3873548-0943-4279-8130-AE8B80152F12

Q34457273-C7247C33-E7D9-464E-B7D3-BCE904BC41A5

Q34457273-E6A8F4FB-32B9-41C5-ACFE-B882A58B3842

P2860

Q34457273-00F2A063-FA32-45A4-8FC6-8406DB2FE992

Q34457273-02A2021A-8214-4DBE-9803-5C4F3A39C49D

Q34457273-1EC52AED-6EA6-457F-908B-8CA4D1FAEFC0

Q34457273-24034C76-5C85-47BD-B470-7A9B94960A48

Q34457273-2A4787A5-211D-498D-94A6-A3B4DC99DA6A

Q34457273-3F215E07-8B60-4773-8AFA-8879237A3FF8

Q34457273-415F1768-A6FD-4F75-AAFF-FE6CF59DBCC9

Q34457273-4402B460-7D3E-4D67-A247-404DFB1288E6

Q34457273-49A20114-6A91-4EC3-8422-EFAB969595A4

Q34457273-4CB6E0C5-2DBC-4A2A-A8FD-FD7B796FA7EC

P304

Q34457273-099DA2A6-CD8B-4B9C-9E8D-1DC6175FD3FA

P31

Q34457273-907A273A-40F4-4D8D-BDCD-A879270F0A99

P356

Q34457273-A0602CB4-E6A3-45FA-A655-D91770551429

P433

Q34457273-17B90B09-97BE-46C9-BE06-F935E91B34C8

P478

Q34457273-9C3ECECC-4E2E-483C-ADF6-BE597F311840

P50

Q34457273-70F7FFF3-7026-4140-9745-CE04CA54EC68

Q34457273-85817F1D-B8FE-407D-90E3-ED48A43D2588

Q34457273-CD978732-4CF8-4137-853D-2E6B732F2686

Q34457273-CEC2F61A-F881-48F9-984A-DDD28CE4A5A5

P577

Q34457273-0FFFA76F-546B-42F2-8A5D-1D122877C4BE

P698

Q34457273-5A05281B-A16A-4245-B313-F1713E5F8937

P932

Q34457273-7884026C-D2AA-46BE-B513-1DA6E4FB0327

P356

P1433

Journal of the American Society of Nephrology

P1476

The Sweet Pee model for Sglt2 mutation

@en

P2093

Ann Flenniken

http://www.w3.org/2001/XMLSchema#string

Gavasker Sivaskandarajah

http://www.w3.org/2001/XMLSchema#string

Jon M Barasch

http://www.w3.org/2001/XMLSchema#string

Joseph P Ly

http://www.w3.org/2001/XMLSchema#string

Joseph V Bonventre

http://www.w3.org/2001/XMLSchema#string

Jurgen Schnermann

http://www.w3.org/2001/XMLSchema#string

Karen Sison

http://www.w3.org/2001/XMLSchema#string

Lingli Li

http://www.w3.org/2001/XMLSchema#string

Lucy Osborne

http://www.w3.org/2001/XMLSchema#string

Susan E Quaggin

http://www.w3.org/2001/XMLSchema#string

P2860

Selective translational repression of truncated proteins from frameshift mutation-derived mRNAs in tumors

The canonical UPF1-dependent nonsense-mediated mRNA decay is inhibited in transcripts carrying a short open reading frame independent of sequence context

Analyzing real-time PCR data by the comparative C(T) method

Molecular analysis of the SGLT2 gene in patients with renal glucosuria

A novel missense mutation in SLC5A2 encoding SGLT2 underlies autosomal-recessive renal glucosuria and aminoaciduria

A novel spontaneous mutation of Irs1 in mice results in hyperinsulinemia, reduced growth, low bone mass and impaired adipogenesis.

The impact of CFNS-causing EFNB1 mutations on ephrin-B1 function

Mouse ENU mutagenesis.

Divalent cation transport by the distal nephron: insights from Bartter's and Gitelman's syndromes.

Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications.

P304

113-123

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2010080888

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21209254

http://www.w3.org/2001/XMLSchema#string

P932

3014040

http://www.w3.org/2001/XMLSchema#string